Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta (R) in the prophylactic treatment of chemotherapy-induced neutropenia
European Journal of Cancer(2017)
Key words
neutropenia,prophylactic treatment,eu-neulasta,chemotherapy-induced
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined